OC
AMPH icon

Oakworth Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Oakworth Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,874
Closed -$49.9K – 859
2025
Q3 		$49.9K Sell
1,874
-4,126
-69% -$107K ﹤0.01% 435
2025
Q2 		$138K Hold
6,000
– – 0.01% 249
2025
Q1 		$174K Buy
6,000
+977
+19% +$31.2K 0.01% 227
2024
Q4 		$187K Hold
5,023
– – 0.01% 220
2024
Q3 		$244K Hold
5,023
– – 0.02% 190
2024
Q2 		$201K Buy
+5,023
New +$208K 0.01% 200

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oakworth Capital's AMPH Position: Q4 2025 in Review

Oakworth Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2025, closing a stake of 1,874 shares — an estimated $49.9K sold.

Oakworth Capital first reported a position in AMPH in Q2 2024 and held it in 6 quarters. The position peaked at $244K in Q3 2024. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • Oakworth Capital reported no remaining Amphastar Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Oakworth Capital sold 1,874 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $49.9K.
  • Oakworth Capital first reported a position in Amphastar Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • Oakworth Capital's Amphastar Pharmaceuticals position peaked at $244K in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Oakworth Capital's 13F filing for Q4 2025, filed 30 Jan 2026.